LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

Начало・Списък с акции・Pulse Biosciences Inc

Pulse Biosciences Inc

Затворен

СекторЗдравеопазване

15.16 5.64

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

15.01

Максимум

15.25

Ключови измерители
By Trading Economics
Приходи	-217K -19M
Продажби	86K 86K
EPS	-0.29
Марж на печалбата	-22,540.698
Служители	75
EBITDA	-228K -19M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+44.17% upside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-179M 958M
Предишно отваряне	9.52
Предишно затваряне	15.16

Настроения в новините

By Acuity

34%

66%

79 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

16.59 / 17.17 Подкрепа & съпротива

Pulse Biosciences Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

19.12.2025 г., 17:29 ч. UTC

Придобивния, сливания и поглъщания

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- 2nd Update

19.12.2025 г., 16:47 ч. UTC

Значими двигатели на пазара

Galectin Shares Fall After FDA Raises Issues With Belapectin Program

19.12.2025 г., 16:10 ч. UTC

Придобивния, сливания и поглъщания

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- Update

20.12.2025 г., 19:00 ч. UTC

Печалби

Consumer Confidence, Economic Activity Data, and a Short Trading Week for Christmas -- Barrons.com

19.12.2025 г., 22:33 ч. UTC

Печалби

Volkswagen Halts Imports of Its Electric Bus to U.S. Next Year -- WSJ

19.12.2025 г., 22:19 ч. UTC

Печалби

FedEx Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

19.12.2025 г., 21:48 ч. UTC

Придобивния, сливания и поглъщания

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19.12.2025 г., 21:44 ч. UTC

Печалби

These Stocks Moved the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

19.12.2025 г., 21:38 ч. UTC

Печалби

Get Ready for New Chip Shortages. Micron's Success All But Guarantees It. -- Barrons.com

19.12.2025 г., 21:00 ч. UTC

Пазарно говорене

BEA's Trade-Data Catchup Will Continue Into January -- Market Talk

19.12.2025 г., 20:23 ч. UTC

Пазарно говорене

Oil Futures End Down Week on Up Note -- Market Talk

19.12.2025 г., 20:14 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Post Daily Gain, Weekly Loss -- Market Talk

19.12.2025 г., 18:38 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Falls By 8 to 406 -- Market Talk

19.12.2025 г., 18:00 ч. UTC

Пазарно говорене

Печалби

Nike's Margin Outlook Shows Quarter-to-Quarter Improvement -- Market Talk

19.12.2025 г., 17:41 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

19.12.2025 г., 17:24 ч. UTC

Пазарно говорене

Печалби

Nike's North America Business is Bright Spot in Turnaround -- Market Talk

19.12.2025 г., 17:20 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Tech, Media & Telecom Roundup: Market Talk

19.12.2025 г., 17:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

19.12.2025 г., 16:29 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Oracle, Nike, FedEx, Micron, DJT, Carnival, BioMarin, Lamb Weston, Winnebago, and More -- Barrons.com

19.12.2025 г., 16:20 ч. UTC

Придобивния, сливания и поглъщания

CPKC: Anticipates Submitting Comments to Surface Transportation Board in Accordance With Procedural Schedule

19.12.2025 г., 16:19 ч. UTC

Придобивния, сливания и поглъщания

CPKC: Approval of Union Pacific-Norfolk Southern Merger Isn't Inevitable

19.12.2025 г., 16:18 ч. UTC

Придобивния, сливания и поглъщания

CPKC: Will Be Thoroughly Reviewing Union Pacific-Norfolk Southern Merger Application Over Coming Days

19.12.2025 г., 16:16 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

19.12.2025 г., 16:16 ч. UTC

Пазарно говорене

U.K. Public Borrowing Data Shows Slow Progress in Reducing Fiscal Deficit -- Market Talk

19.12.2025 г., 16:05 ч. UTC

Придобивния, сливания и поглъщания

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19.12.2025 г., 16:04 ч. UTC

Придобивния, сливания и поглъщания

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19.12.2025 г., 15:37 ч. UTC

Пазарно говорене

U.S. Labor Market Weakness Could Cause Further Fed Rate Cuts -- Market Talk

19.12.2025 г., 15:21 ч. UTC

Пазарно говорене

West-Coast Liquor Store Strike Weighed on Canada Retail Data -- Market Talk

19.12.2025 г., 15:09 ч. UTC

Пазарно говорене

Gold Flat But Set for Weekly Gains -- Market Talk

19.12.2025 г., 15:09 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Pulse Biosciences Inc Прогноза

Ценова цел

By TipRanks

44.17% нагоре

12-месечна прогноза

Среден 22 USD 44.17%

Висок 22 USD

Нисък 22 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Pulse Biosciences Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Pulse Biosciences Inc през последните 3 месеца.

Техническа оценка

By Trading Central

16.59 / 17.17Подкрепа & съпротива

Recent bearish events outweigh bullish events.

Настроение

By Acuity

79 / 374 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.